Standard-of-Care Therapy

OTHER4 trials

Conditions

Metastatic Colorectal Cancer (mCRC)Metastatic Malignant NeoplasmPhysical ActivityPost OperativePost Operative AnalgesiaRecurrent Malignant NeoplasmUrogynecologic Surgery

Phase 2

Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT II)

Active, not recruitingNCT02152254

M.D. Anderson Cancer CenterMetastatic Malignant Neoplasm, Recurrent Malignant Neoplasm

Start: 2014-05-13End: 2030-12-31Target: 1362Updated: 2026-08-10

Postoperative Tizanidine Use in Pelvic Reconstructive Surgery: A Pilot Study

Not yet recruitingNCT07766837

Hartford HospitalPost Operative, Post Operative Analgesia, Urogynecologic Surgery

Start: 2026-07-29End: 2028-07-29Target: 186Updated: 2026-08-17

Unknown Phase

Sit-to-Stand Progression Using Movi Chair vs Traditional Practices

WithdrawnNCT03103464

University of Alabama at BirminghamPhysical Activity

Start: 2018-05-01End: 2018-07-31Updated: 2018-08-10

Evaluation of a Diagnostic Test to Identify the Best Drugs for Treatment of Metastatic Colorectal Cancer

RecruitingNCT07171554

Oncosyne ASMetastatic Colorectal Cancer (mCRC)

Start: 2025-10-28End: 2029-06-01Target: 75Updated: 2026-04-30

Journal of Clinical Oncology2026-05-27

Clinical outcomes of patients with PI3K pathway alterations by treatment type: The MD Anderson Cancer Center IMPACT 2 study.

Journal of Clinical Oncology2026-05-27

Clinical outcomes of patients with RTK-RAS pathway alterations by treatment type: The MD Anderson Cancer Center IMPACT 2 study.

Journal of Clinical Oncology2026-05-27

Clinical outcomes of patients with cell cycle alterations by treatment type: The MD Anderson Cancer Center IMPACT 2 study.

Journal of Clinical Oncology2026-05-27

Concordance analysis of DNA and RNA profiling: The MD Anderson IMPACT2 study in precision oncology

Signal Transduction and Targeted Therapy2026-02-24

Clinical outcomes of patients with or without DNA repair pathway alterations by treatment type: The MD Anderson Cancer Center IMPACT 2 study.

Journal of Clinical Oncology2025-05-28

Results of IMPACT 2, a randomized study evaluating molecular profiling and targeted agents in metastatic cancer at MD Anderson Cancer Center.

Journal of Clinical Oncology2024-06-01

Challenges and opportunities associated with the MD Anderson IMPACT2 randomized study in precision oncology

npj Precision Oncology2022-10-2715 citations

Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT2): Challenges and Opportunities in Conducting an MD Anderson Randomized Study in Precision Oncology.

Journal of Clinical Oncology2021-05-20

Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial

Genome Medicine2021-05-1853 citations

Precision medicine: preliminary results from the Initiative for Molecular Profiling and Advanced Cancer Therapy 2 (IMPACT2) study.

2021-03-1921 citations

Prolonged response to treatment based on cell-free DNA analysis and molecular profiling in three patients with metastatic cancer: a case series

Therapeutic Advances in Medical Oncology2021-01-016 citations

Long-term overall survival and prognostic score predicting survival: the IMPACT study in precision medicine.

2019-12-3053 citations

Disease activity states of the DAPSA, a psoriatic arthritis specific instrument, are valid against functional status and structural progression.

2016-07-2556 citations

Standard-of-Care Therapy

Sponsors

Conditions

Phase 2

Unknown Phase

Related Papers